Encompass Health Corporation (NYSE:EHC) Stock Position Lowered by Leeward Investments LLC MA

Leeward Investments LLC MA decreased its holdings in Encompass Health Corporation (NYSE:EHC - Free Report) by 4.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 432,357 shares of the company's stock after selling 18,517 shares during the quarter. Encompass Health makes up 2.3% of Leeward Investments LLC MA's investment portfolio, making the stock its biggest holding. Leeward Investments LLC MA owned approximately 0.43% of Encompass Health worth $43,789,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in EHC. Colonial Trust Co SC bought a new position in shares of Encompass Health in the 4th quarter worth about $29,000. Transce3nd LLC acquired a new stake in Encompass Health during the fourth quarter worth approximately $40,000. CBIZ Investment Advisory Services LLC lifted its stake in Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after buying an additional 127 shares during the period. Signaturefd LLC boosted its holdings in shares of Encompass Health by 21.6% during the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock worth $65,000 after buying an additional 125 shares in the last quarter. Finally, Arlington Trust Co LLC grew its position in shares of Encompass Health by 22.9% during the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock worth $68,000 after buying an additional 125 shares during the period. Institutional investors own 97.25% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on EHC shares. Royal Bank Of Canada lifted their price target on shares of Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a research note on Monday, April 28th. Stephens raised Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 target price for the company in a research report on Thursday, June 5th. Truist Financial reiterated a "buy" rating and issued a $135.00 price target (up previously from $116.00) on shares of Encompass Health in a report on Monday, April 28th. KeyCorp boosted their price objective on Encompass Health from $122.00 to $135.00 and gave the company an "overweight" rating in a report on Tuesday, May 27th. Finally, UBS Group increased their target price on Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a report on Monday, April 28th. Eight analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of $127.00.

Encompass Health Stock Up 0.1%

Shares of EHC traded up $0.16 on Friday, reaching $119.04. The company's stock had a trading volume of 400,752 shares, compared to its average volume of 703,217. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.81. Encompass Health Corporation has a twelve month low of $82.74 and a twelve month high of $123.13. The stock has a market capitalization of $12.00 billion, a PE ratio of 24.60, a PEG ratio of 2.41 and a beta of 0.88. The firm has a fifty day moving average of $119.27 and a 200-day moving average of $105.22.

Encompass Health (NYSE:EHC - Get Free Report) last posted its earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, topping analysts' consensus estimates of $1.19 by $0.18. Encompass Health had a net margin of 8.97% and a return on equity of 17.63%. The company had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same quarter in the prior year, the business posted $1.12 EPS. The firm's revenue was up 10.6% compared to the same quarter last year. Equities analysts predict that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.57%. The ex-dividend date of this dividend is Tuesday, July 1st. Encompass Health's payout ratio is 14.05%.

Insiders Place Their Bets

In other Encompass Health news, CEO Mark J. Tarr sold 118,384 shares of the company's stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total value of $14,387,207.52. Following the completion of the sale, the chief executive officer directly owned 527,070 shares of the company's stock, valued at approximately $64,054,817.10. This represents a 18.34% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the business's stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total transaction of $498,974.19. Following the completion of the transaction, the insider owned 11,958 shares in the company, valued at approximately $1,394,422.38. The trade was a 26.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 132,663 shares of company stock valued at $16,034,082. Corporate insiders own 2.00% of the company's stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.